MiR-1 and miR-206 has already been described to be deregulated in ALS patients [40,41,42], while in previous studies miR-141 and miR-200 were reported as related to ALS since they bind a sequence in FUS promoter and in turn have an impact on FUS protein synthesis [43,44]. Here, FUS is linked to amyotrophic lateral sclerosis.